Facing NASH Therapeutic Skepticism with 89bio's Rohan Palekar
Business Of Biotech
00:00
Efficiently Advancing Biotech Company's Mission
The chapter highlights how the company, 89 Bio, efficiently worked towards their mission by merging studies, diversifying into a second indication, and employing strategic thinking and creative trial designs. The speakers emphasize the importance of cash management and fiscal stewardship, focusing on patient-oriented and science-driven decision making. They also discuss the speaker's transition from finance to running biological businesses and the significance of scaling up manufacturing.
Transcript
Play full episode
